Lung Adenocarcinoma

general

A carcinoma that arises from the lung and is characterized by the presence of malignant glandular epithelial cells. There is a male predilection with a male to female ratio of 2:1. Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding. If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever. Tobacco smoke is a known risk factor.

83

Centers

220

Active Trials

$2.4B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Lung Adenocarcinoma(83)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
79.2
2
NCI Comprehensive
High-Volume Research Center
78.7
3
NCI Clinical
High-Volume Research Center
77.4
4
NCI Comprehensive
High-Volume Research Center
76.9
5
NCI Comprehensive
High-Volume Research Center
76.5
6
High-Volume Research Center
76.0
7
NCI Comprehensive
High-Volume Research Center
74.3
8
High-Volume Research Center
72.9
9
NCI Comprehensive
High-Volume Research Center
72.4
10
NCI Comprehensive
High-Volume Research Center
71.9
11
NCI Comprehensive
Active Research Program
68.2
12
NCI Comprehensive
Active Research Program
66.0
13
NCI Comprehensive
Active Research Program
64.0
14
Active Research Program
61.9
15
Active Research Program
61.5
16
NCI Comprehensive
Active Research Program
61.0
17
NCI Comprehensive
Active Research Program
60.8
18
Active Research Program
60.1
19
Active Research Program
59.4
20
NCI Comprehensive
Active Research Program
58.5
2158.3
22
NCI Comprehensive
Active Research Program
58.3
23
NCI Comprehensive
Active Research Program
58.3
24
NCI Clinical
Active Research Program
56.7
25
NCI Comprehensive
Active Research Program
55.8
26
NCI Comprehensive
Active Research Program
54.4
27
NCI Comprehensive
Active Research Program
52.7
28
NCI Comprehensive
Active Research Program
52.2
29
NCI Comprehensive
Active Research Program
51.9
30
Active Research Program
51.9
31
NCI Clinical
Active Research Program
51.9
32
Active Research Program
51.9
33
NCI Comprehensive
Active Research Program
51.9
34
Active Research Program
51.9
35
Active Research Program
51.9
36
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
51.7
37
NCI Comprehensive
Active Research Program
51.4
38
NCI Comprehensive
Active Research Program
50.9
39
NCI Clinical
Active Research Program
50.8
40
NCI Basic_laboratory
Active Research Program
50.5
41
NCI Comprehensive
Active Research Program
49.5
42
NCI Comprehensive
Active Research Program
49.4
43
NCI Comprehensive
Active Research Program
48.6
44
Active Research Program
48.5
4548.2
46
NCI Comprehensive
Active Research Program
47.7
47
NCI Comprehensive
Active Research Program
47.3
48
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
47.2
49
NCI Comprehensive
Active Research Program
46.8
50
NCI Comprehensive
Active Research Program
46.4
51
NCI Comprehensive
Active Research Program
45.5
52
NCI Comprehensive
Active Research Program
43.2
53
NCI Comprehensive
Active Research Program
42.3
54
NCI Comprehensive
Active Research Program
40.5
55
NCI Comprehensive
Active Research Program
39.9
56
NCI Comprehensive
Active Research Program
39.9
57
Active Research Program
39.9
58
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
39.9
59
NCI Comprehensive
Active Research Program
39.9
60
Active Research Program
39.9
61
NCI Comprehensive
Active Research Program
39.9
62
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
39.9
63
NCI Comprehensive
Active Research Program
39.9
6439.9
65
NCI Basic_laboratory
Active Research Program
39.9
66
Active Research Program
39.9
67
Active Research Program
39.9
68
NCI Comprehensive
Active Research Program
38.6
69
NCI Comprehensive
Active Research Program
38.2
70
Active Research Program
35.5
71
NCI Comprehensive
25.0
72
NCI Comprehensive
25.0
73
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
25.0
7425.0
7525.0
7625.0
7725.0
78
79
NCI Comprehensive
80
81
82
83

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →